all report title image
  • Published In : Apr 2024
  • Code : CMI774
  • Pages : 170
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Global aptamers market is estimated to be valued at USD 7.29 Bn in 2024 and is expected to exhibit a CAGR of 17.8% during the forecast period (2024-2031). Aptamers are single stranded Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA) molecules that bind to a specific target molecule. These can be chemically synthesized to recognize and bind protein, small molecule or cell surface targets with high affinity and specificity. Aptamers have several advantages over antibodies such as small size, easy production and modification, lack of immunogenicity and better tissue penetration. These have wide applications in research, diagnostics, therapeutics and others.

Market Dynamics:

Global aptamers market growth is driven by rising research and development investments in life sciences and pharmaceutical industries. Growing use of aptamers as an alternative to antibodies in diagnostics and research due to their advantages is also boosting the market growth. However, high costs associated with aptamer development and production is a major factor hampering the market growth. Emergence of novel technologies for simpler and cost-effective production of aptamers provides a significant opportunity for market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global aptamers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global aptamers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study AstraZeneca, Achiko AG, Agilent Technologies, Inc., Amsbio, Aptagen LLC, Aptamer Group, CAGE Bio Inc., GC Biopharma Corp., GlyTech, Inc., IVERIC bio, Inc., NeoNeuro SAS, Novartis AG, Ophthotech Corporation, SomaLogic Operating Co., Inc., TAGCyx Biotechnologies Inc., Vivonics Inc., Zentek Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global aptamers market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market.

Detailed Segmentation-

  • By Type:
    • Nucleic Acid
      • DNA-based Aptamers
      • RNA-based Aptamers
      • XNA-based Aptamers
    • Peptide Aptamers
  • By Application:
    • Diagnostics
    • Therapeutics
    • Research and Development
  • By End User:
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutions
    • Contract Research Organization
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa

Company Profiles:

  • AstraZeneca
  • Achiko AG
  • Agilent Technologies, Inc.
  • Amsbio
  • Aptagen LLC,
  • Aptamer Sciences, Inc.
  • CAGE Bio Inc.
  • GC Biopharma Corp.
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Type
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Manufacturer Revenue
    • Acquisitions and Partnerships Scenario
    • Product Launches/Approvals
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Aptamers Market- Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the market
  5. Global Aptamers Market, By Type, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Nucleic Acid
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn) 
        • DNA-based Aptamers
        • RNA-based Aptamers
        • XNA-based Aptamers
    • Peptide Aptamers
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  6. Global Aptamers Market, By Application, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Diagnostics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Therapeutics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Research and Development
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  7. Global Aptamers Market, By End User, 2019 – 2031, (USD Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2019 – 2031
      • Segment Trends
    • Biotechnology and Pharmaceutical Companies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Academic and Research Institutions
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
    • Contract Research Organization
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
  8. Global Aptamers Market, By Region, 2019 – 2031, (USD Bn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2019–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • AstraZeneca
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Achiko AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Agilent Technologies, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Amsbio
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Aptagen LLC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Aptamer Group
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • CAGE Bio Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GC Biopharma Corp.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • GlyTech, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • IVERIC bio, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • NeoNeuro SAS
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Ophthotech Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • SomaLogic Operating Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • TAGCyx Biotechnologies Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Vivonics Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Zentek Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 32 figures on "Aptamers Market” -Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

Esomar
Duns
Clutch
DMCA

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo